Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alan B Rickinson

Showing results (11-20 of 91) with videos related to

Pageof 10
Sort By:
Plos Pathogens|September 25, 2018
Proteome-wide analysis of CD8+ T cell responses to EBV reveals differences between primary and persistent infectionCalum Forrest, Andrew D Hislop, Alan B Rickinson, et al.
Seminars in Cancer Biology|July 22, 2009
Burkitt's lymphoma: the Rosetta Stone deciphering Epstein-Barr virus biologyMartin Rowe, Gemma L Kelly, Andrew I Bell, et al.
Annual Review of Immunology|March 24, 2007
Cellular responses to viral infection in humans: lessons from Epstein-Barr virusAndrew D Hislop, Graham S Taylor, Delphine Sauce, et al.
The Journal of Experimental Medicine|February 3, 2005
CD8+ immunodominance among Epstein-Barr virus lytic cycle antigens directly reflects the efficiency of antigen presentation in lytically infected cellsVictoria A Pudney, Alison M Leese, Alan B Rickinson, et al.
The Journal of General Virology|November 21, 2001
Genetic analysis of the Epstein-Barr virus-coded leader protein EBNA-LP as a co-activator of EBNA2 functionEamon M McCann, Gemma L Kelly, Alan B Rickinson, et al.
Journal of Virology|September 30, 2011
Epstein-Barr virus BamHI W repeat number limits EBNA2/EBNA-LP coexpression in newly infected B cells and the efficiency of B-cell transformation: a rationale for the multiple W repeats in wild-type virus strainsRosemary J Tierney, Kuan-Yu Kao, Jasdeep K Nagra, et al.
Trends in Immunology|March 5, 2014
Cellular immune controls over Epstein-Barr virus infection: new lessons from the clinic and the laboratoryAlan B Rickinson, Heather M Long, Umaimainthan Palendira, et al.
Journal of Virology|December 26, 2014
The Epstein-Barr virus BamHI C promoter is not essential for B cell immortalization in vitro, but it greatly enhances B cell growth transformationRosemary J Tierney, Jasdeep Nagra, Martin Rowe, et al.
The Journal of Experimental Medicine|April 3, 2002
Epitope-specific evolution of human CD8(+) T cell responses from primary to persistent phases of Epstein-Barr virus infectionAndrew D Hislop, Nicola E Annels, Nancy H Gudgeon, et al.
Journal of Virology|April 14, 2005
Regression of Epstein-Barr virus-induced B-cell transformation in vitro involves virus-specific CD8+ T cells as the principal effectors and a novel CD4+ T-cell reactivityNancy H Gudgeon, Graham S Taylor, Heather M Long, et al.
Pageof 10

Showing results (11-20 of 91) with videos related to

Sort By:
Pageof 10
Plos Pathogens|September 25, 2018
Proteome-wide analysis of CD8+ T cell responses to EBV reveals differences between primary and persistent infectionCalum Forrest, Andrew D Hislop, Alan B Rickinson, et al.
Seminars in Cancer Biology|July 22, 2009
Burkitt's lymphoma: the Rosetta Stone deciphering Epstein-Barr virus biologyMartin Rowe, Gemma L Kelly, Andrew I Bell, et al.
Annual Review of Immunology|March 24, 2007
Cellular responses to viral infection in humans: lessons from Epstein-Barr virusAndrew D Hislop, Graham S Taylor, Delphine Sauce, et al.
The Journal of Experimental Medicine|February 3, 2005
CD8+ immunodominance among Epstein-Barr virus lytic cycle antigens directly reflects the efficiency of antigen presentation in lytically infected cellsVictoria A Pudney, Alison M Leese, Alan B Rickinson, et al.
The Journal of General Virology|November 21, 2001
Genetic analysis of the Epstein-Barr virus-coded leader protein EBNA-LP as a co-activator of EBNA2 functionEamon M McCann, Gemma L Kelly, Alan B Rickinson, et al.
Journal of Virology|September 30, 2011
Epstein-Barr virus BamHI W repeat number limits EBNA2/EBNA-LP coexpression in newly infected B cells and the efficiency of B-cell transformation: a rationale for the multiple W repeats in wild-type virus strainsRosemary J Tierney, Kuan-Yu Kao, Jasdeep K Nagra, et al.
Trends in Immunology|March 5, 2014
Cellular immune controls over Epstein-Barr virus infection: new lessons from the clinic and the laboratoryAlan B Rickinson, Heather M Long, Umaimainthan Palendira, et al.
Journal of Virology|December 26, 2014
The Epstein-Barr virus BamHI C promoter is not essential for B cell immortalization in vitro, but it greatly enhances B cell growth transformationRosemary J Tierney, Jasdeep Nagra, Martin Rowe, et al.
The Journal of Experimental Medicine|April 3, 2002
Epitope-specific evolution of human CD8(+) T cell responses from primary to persistent phases of Epstein-Barr virus infectionAndrew D Hislop, Nicola E Annels, Nancy H Gudgeon, et al.
Journal of Virology|April 14, 2005
Regression of Epstein-Barr virus-induced B-cell transformation in vitro involves virus-specific CD8+ T cells as the principal effectors and a novel CD4+ T-cell reactivityNancy H Gudgeon, Graham S Taylor, Heather M Long, et al.
Pageof 10